(VIANEWS) – Blue Bird Corporation (BLBD), KBR (KBR), BioMarin Pharmaceutical (BMRN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Blue Bird Corporation (BLBD)
25.6% sales growth and 134.71% return on equity
Some better-ranked stocks in the auto space are Dorman Products, Inc. (DORM Quick QuoteDORM – Free Report) , Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) and Douglas Dynamics, Inc. (PLOW Quick QuotePLOW – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present.
Blue Bird Corporation, together with its subsidiaries, designs, engineers, manufactures, and sells school buses in the United States, Canada, and internationally. The company operates through two segments, Bus and Parts. It offers Type C, Type D, and specialty buses; and alternative power options through its propane powered, gasoline powered, compressed natural gas powered, and electric powered school buses, as well as diesel engines. The company also sells replacement bus parts; and provides financing services and extended warranties related to its products. Blue Bird Corporation sells its products through drop ship fulfillment and a network of dealers, as well as directly to fleet operators, the United States government, and state governments; independent service centers; and maintains a parts distribution center. The company was formerly known as Hennessy Capital Acquisition Corp and changed its name to Blue Bird Corporation. Blue Bird Corporation was founded in 1927 and is headquartered in Macon, Georgia.
Earnings Per Share
As for profitability, Blue Bird Corporation has a trailing twelve months EPS of $3.01.
PE Ratio
Blue Bird Corporation has a trailing twelve months price to earnings ratio of 16.19. Meaning, the purchaser of the share is investing $16.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 134.71%.
Sales Growth
Blue Bird Corporation’s sales growth is 7.3% for the current quarter and 25.6% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 1.5% and a drop 3.3% for the next.
Previous days news about Blue Bird Corporation(BLBD)
- According to Zacks on Monday, 16 September, "Some better-ranked stocks in the auto space are Dorman Products, Inc. (DORM Quick QuoteDORM – Free Report) and Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Monday, 16 September, "Some better-ranked stocks in the auto space are Dorman Products, Inc. (DORM Quick QuoteDORM – Free Report) and Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Tuesday, 17 September, "Some better-ranked stocks in the auto space are Dorman Products, Inc. (DORM Quick QuoteDORM – Free Report) , Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) and Douglas Dynamics, Inc. (PLOW Quick QuotePLOW – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
- According to Zacks on Tuesday, 17 September, "Some better-ranked stocks in the auto space are Dorman Products, Inc. (DORM Quick QuoteDORM – Free Report) , Blue Bird Corporation (BLBD Quick QuoteBLBD – Free Report) and Douglas Dynamics, Inc. (PLOW Quick QuotePLOW – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. "
2. KBR (KBR)
14.1% sales growth and 13.42% return on equity
KBR, Inc. provides professional services and technologies across the asset and program life-cycle within the government services and hydrocarbons industries worldwide. The company operates through three segments: Government Solutions, Technology Solutions, and Energy Solutions. The Government Solutions segment offers life-cycle support solutions to defense, space, aviation, and other programs and missions for military and other government agencies in the United States, the United Kingdom, and Australia. This segment's services cover from research and development, through systems engineering, test and evaluation, systems integration and program management, to operations support, maintenance, and field logistics. The Technology Solutions segment provides proprietary technologies, equipment and catalyst supply, digital solutions and associated knowledge-based services into a global business for refining, petrochemicals, inorganic, and specialty chemicals, as well as gasification, syngas, ammonia, nitric acid and fertilizers. The Energy Solutions segment offers life-cycle support solutions across the upstream, midstream, and downstream hydrocarbons markets; comprehensive project and program delivery solutions, as well as engineering services, front-end consulting and feasibility studies, sustaining capital construction, turnarounds, maintenance services, and others. This segment provides EPC, and consulting and engineering services for onshore oil and gas; LNG/GTL; oil refining; petrochemicals; chemicals; fertilizers; offshore oil and gas; and floating solutions. KBR, Inc. was founded in 1901 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, KBR has a trailing twelve months EPS of $1.46.
PE Ratio
KBR has a trailing twelve months price to earnings ratio of 42.62. Meaning, the purchaser of the share is investing $42.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.42%.
Yearly Top and Bottom Value
KBR’s stock is valued at $62.23 at 16:22 EST, way under its 52-week high of $69.50 and way higher than its 52-week low of $49.37.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 16, 2024, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 0.97%.
Previous days news about KBR(KBR)
- According to Zacks on Tuesday, 17 September, "CACI International operates in a highly competitive defense, space, intelligence and mission-critical services market that comprises contenders, including Science Applications International (SAIC Quick QuoteSAIC – Free Report) , Leidos Holdings (LDOS Quick QuoteLDOS – Free Report) and KBR Inc. (KBR Quick QuoteKBR – Free Report) .", "CACI’s competitors, Science Applications International, KBR and Leidos, are established players in the industry with their respective strengths. "
- KBR wins $140m US air force follow-on task order, aids GS backlog. According to Zacks on Tuesday, 17 September, "Leveraging its rapid prototyping capabilities, KBR will develop prototypes for essential safety hardware, including the T-38 Canopy Transparency.", "As a trusted partner, KBR will provide critical engineering tasks to ensure the operational safety, suitability, and effectiveness of systems under the Air Force Life Cycle Management Center (AFLCMC).KBR’s experts will continue conducting research and analyses to enhance reliability, maintainability, and life cycle management, among other key areas, at Hill Air Force Base in Utah and other locations. "
3. BioMarin Pharmaceutical (BMRN)
14% sales growth and 5.1% return on equity
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; BMN 307, an AAV5 mediated gene therapy, which is in Phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; and BMN 255 that is in Phase 1/2 clinical trial for treating primary hyperoxaluria. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Earnings Per Share
As for profitability, BioMarin Pharmaceutical has a trailing twelve months EPS of $1.32.
PE Ratio
BioMarin Pharmaceutical has a trailing twelve months price to earnings ratio of 52.92. Meaning, the purchaser of the share is investing $52.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.1%.
Volume
Today’s last reported volume for BioMarin Pharmaceutical is 10510300 which is 381.08% above its average volume of 2184720.
4. Gilat Satellite Networks Ltd. (GILT)
14% sales growth and 7.39% return on equity
Gilat Satellite Networks Ltd., together with its subsidiaries, provides satellite-based broadband communication solutions in Israel and internationally. It operates through Fixed Networks, Mobility Solutions, and Terrestrial Infrastructure Projects segments. The company designs and manufactures ground-based satellite communications equipment; and provides solutions and end-to-end services. Its portfolio consists of very small aperture terminals, amplifiers, modems, on-the-move antennas, solid state power amplifiers, block upconverters, transceivers, low-profile antennas, and on-the-move/on-the-pause terminals and modems. The company also offers turnkey integrated solutions, including managed satellite network services, network planning and optimization, satellite capacity, remote network operation, call center support, hub and field operations, and communication networks construction and installation services. In addition, it provides connectivity services, Internet access, and telephony services to enterprise, government, and residential customers; and builds telecommunication infrastructure using fiber-optic and wireless technologies for broadband connectivity. The company sells its products and solutions to communication service providers, satellite operators, governments, mobile network operators, telecommunication companies, and system integrators, as well as to defense and homeland security organizations, and directly to end-users. Gilat Satellite Networks Ltd. was incorporated in 1987 and is headquartered in Petah Tikva, Israel.
Earnings Per Share
As for profitability, Gilat Satellite Networks Ltd. has a trailing twelve months EPS of $0.35.
PE Ratio
Gilat Satellite Networks Ltd. has a trailing twelve months price to earnings ratio of 13.14. Meaning, the purchaser of the share is investing $13.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.4%, now sitting on 292.25M for the twelve trailing months.
5. Allegheny Technologies Incorporated (ATI)
12.5% sales growth and 28.61% return on equity
Allegheny Technologies Incorporated manufactures and sells specialty materials and components worldwide. The company operates in two segments, High Performance Materials & Components and Advanced Alloys & Solutions. The company produces high performance materials, including titanium and titanium-based alloys; nickel-and cobalt-based alloys and superalloys; zirconium and related alloys, such as hafnium and niobium; powder alloys; and other specialty materials in long product forms of ingots, billets, bars, rods, wires, and shapes and rectangles, as well as seamless tubes, plus precision forgings, castings, components, and machined parts to the aerospace and defense, medical, oil and gas, and electrical energy markets. It also provides stainless steel, nickel-based alloys, specialty alloys, and titanium and titanium-based alloys in various product forms, including plate, sheet, and precision rolled strip products to various markets, such as chemical and hydrocarbon processing,. Allegheny Technologies Incorporated was founded in 1960 and is based in Pittsburgh, Pennsylvania.
Earnings Per Share
As for profitability, Allegheny Technologies Incorporated has a trailing twelve months EPS of $2.65.
PE Ratio
Allegheny Technologies Incorporated has a trailing twelve months price to earnings ratio of 22.46. Meaning, the purchaser of the share is investing $22.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.61%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.7%, now sitting on 4.23B for the twelve trailing months.
Moving Average
Allegheny Technologies Incorporated’s value is under its 50-day moving average of $61.61 and way higher than its 200-day moving average of $52.46.
Yearly Top and Bottom Value
Allegheny Technologies Incorporated’s stock is valued at $59.53 at 16:22 EST, way under its 52-week high of $68.92 and way above its 52-week low of $35.03.
6. Golar LNG Limited (GLNG)
8.1% sales growth and 7.08% return on equity
Golar LNG Limited designs, builds, owns, and operates marine infrastructure for the liquefaction and regasification of LNG. It operates through Shipping and FLNG segments. The company engages in the operation and chartering of LNG carriers, Floating Liquefaction Natural Gas Vessel (FLNG), and floating storage regasification units (FSRUs), as well as operates external vessels. As of December 31, 2021, it operated nine LNG carriers, one FSRU, and three FLNGs. The company was founded in 1946 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Golar LNG Limited has a trailing twelve months EPS of $1.32.
PE Ratio
Golar LNG Limited has a trailing twelve months price to earnings ratio of 25.22. Meaning, the purchaser of the share is investing $25.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.08%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 16.6%, now sitting on 276.58M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 26, 2024, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 3%.
7. Matson (MATX)
6.7% sales growth and 14.15% return on equity
Matson, Inc., together with its subsidiaries, provides ocean transportation and logistics services. The company's Ocean Transportation segment offers ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, as well as to other island economies in Micronesia. It primarily transports dry containers of mixed commodities, refrigerated commodities, packaged foods and beverages, building materials, automobiles, and household goods; livestock; seafood; general sustenance cargo; and garments, footwear, e-commerce, and other retail merchandise. This segment also operates an expedited service from China to Long Beach, California, and various islands in the South Pacific, as well as Okinawa, Japan; and provides container stevedoring, refrigerated cargo services, inland transportation, container equipment maintenance, and other terminal services to ocean carriers on the Hawaiian islands of Oahu, Hawaii, Maui, and Kauai, as well as in the Alaska locations of Anchorage, Kodiak, and Dutch Harbor. In addition, it offers vessel management services. The Logistics segment provides multimodal transportation brokerage services, including domestic and international rail intermodal, long-haul and regional highway trucking, specialized hauling, flat-bed and project, less-than-truckload, and expedited freight services; less-than-container load consolidation and freight forwarding services; warehousing and distribution services; and supply chain management services. It serves the U.S. military, freight forwarders, retailers, consumer goods, automobile manufacturers, and other customers. The company was formerly known as Alexander & Baldwin Holdings, Inc. and changed its name to Matson, Inc. in June 2012. Matson, Inc. was founded in 1882 and is headquartered in Honolulu, Hawaii.
Earnings Per Share
As for profitability, Matson has a trailing twelve months EPS of $9.46.
PE Ratio
Matson has a trailing twelve months price to earnings ratio of 14.02. Meaning, the purchaser of the share is investing $14.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.15%.
Moving Average
Matson’s worth is higher than its 50-day moving average of $130.27 and way above its 200-day moving average of $117.26.
Sales Growth
Matson’s sales growth is 35.8% for the ongoing quarter and 6.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 3.19B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 1, 2024, the estimated forward annual dividend rate is 1.36 and the estimated forward annual dividend yield is 1.05%.
8. Veeco Instruments (VECO)
5.2% sales growth and 12.51% return on equity
Veeco Instruments Inc., together with its subsidiaries, develops, manufactures, sells, and supports semiconductor and thin film process equipment primarily to make electronic devices worldwide. The company offers laser annealing, ion beam deposition and etch, metal organic chemical vapor deposition, single wafer wet processing and surface preparation, molecular beam epitaxy, and atomic layer deposition and other deposition systems, as well as packaging lithography equipment. Its process equipment systems are used in the production of a range of microelectronic components, including logic, dynamic random-access memory, photonics devices, power electronics, radio frequency filters and amplifiers, thin film magnetic heads, and other semiconductor devices. The company markets and sells its products to integrated device manufacturers and foundries; outsourced semiconductor assembly and test, hard disk drive, and photonics manufacturers; and research centers and universities. Veeco Instruments Inc. was founded in 1945 and is headquartered in Plainview, New York.
Earnings Per Share
As for profitability, Veeco Instruments has a trailing twelve months EPS of $1.53.
PE Ratio
Veeco Instruments has a trailing twelve months price to earnings ratio of 21.05. Meaning, the purchaser of the share is investing $21.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.51%.
